UNSPSC 51285313: Nifurimide

This classification denotes a topical anti-infective agent, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier (SRS UNII) NII0A33SQL. European Medicines Agency schedules Nifurimide in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09266MIG. Nifurimide generally arises in the molecular formula C9H10N4O4. The term NIFURIMIDE is an International Non-Proprietary Name or INN. NIFURIMIDE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix.

Most nations, for tariff and trade purposes, schedule nifurimide under HS 29349990 and SITC 51579. As of Q4 2014, NIFURIMIDE remains US FDA's Preferred Term for this commodity. Nifurimide bears US NLM identifiers UMLS ID C2983966 and NCI Concept Code C90980. SMILES: O=C1N(/N=C/C2OC([N](=O)O)CC2)C(CN1)C.

UNSPSC 51285313 Nifurimide (Commodity) covers pharmaceutical products sourced through state and local health agencies, though recent state and local solicitations under this code tag disparate pharmaceutical purchases rather than nifurimide specifically. The Illinois Department of Public Health and Seminole County, Florida have both issued recent procurement notices tagged to this code, but the actual products being bought—Doxycycline Hyclate, Ciprofloxacin Hydrochloride, Naloxone, and drug deactivation systems—do not align with the nifurimide commodity name. State health departments and county health agencies use cooperative purchasing vehicles and competitive bidding processes to source pharmaceuticals for emergency preparedness and community health initiatives, typically requiring quarterly or annual delivery cycles, electronic bid submission, and compliance with drug-free workplace and E-Verify requirements.

The code shows activity in Florida and Illinois. The Illinois Department of Public Health awarded a piggyback pharmaceutical warehouse contract to Chartwell Rx LLC on August 28, 2026, for $2,999,999.11 over the initial contract term plus two renewal periods, covering Doxycycline Hyclate 100mg and Ciprofloxacin Hydrochloride 500mg in 20-count packages through the MMCAP Infuse consortium; this was a completed award through an Invitation for Bid process, not an open solicitation. Seminole County, Florida issued an IFB (IFB60459723LAS) posted June 30, 2026, with a response deadline of July 26, 2026, seeking 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems annually with quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida; the county required electronic bid submission with all shipping and delivery costs included in pricing. The code appears to function as a catch-all tag for pharmaceutical procurement by state and local health agencies rather than a precise commodity classifier; vendors should verify actual product scope in the RFP or IFB statement of work rather than relying on the UNSPSC code alone.